A genomic exploration identifies mechanisms that may explain adverse cardiovascular effects of COX-2 inhibitors
SCIENTIFIC REPORTS
Authors: Braenne, Ingrid; Willenborg, Christina; Tragante, Vinicius; Kessler, Thorsten; Zeng, Lingyao; Reiz, Benedikt; Kleinecke, Mariana; von Ameln, Simon; Willer, Cristen J.; Laakso, Markku; Wild, Philipp S.; Zeller, Tanja; Wallentin, Lars; Franks, Paul W.; Salomaa, Veikko; Dehghan, Abbas; Meitinger, Thomas; Samani, Nilesh J.; Asselbergs, Folkert W.; Erdmann, Jeanette; Schunkert, Heribert
Abstract
Cyclooxygenase-2 inhibitors (coxibs) are characterized by multiple molecular off-target effects and increased coronary artery disease (CAD) risk. Here, we systematically explored common variants of genes representing molecular targets of coxibs for association with CAD. Given a broad spectrum of pleiotropic effects of coxibs, our intention was to narrow potential mechanisms affecting CAD risk as we hypothesized that the affected genes may also display genomic signals of coronary disease risk. A Drug Gene Interaction Database search identified 47 gene products to be affected by coxibs. We traced association signals in 200-kb regions surrounding these genes in 84,813 CAD cases and 202,543 controls. Based on a threshold of 1 x 10(-5) (Bonferroni correction for 3131 haplotype blocks), four gene loci yielded significant associations. The lead SNPs were rs7270354 (MMP9), rs4888383 (BCAR1), rs6905288 (VEGFA1), and rs556321 (CACNA1E). By additional genotyping, rs7270354 at MMP9 and rs4888383 at BCAR1 also reached the established GWAS threshold for genome-wide significance. The findings demonstrate overlap of genes affected by coxibs and those mediating CAD risk and points to further mechanisms, which are potentially responsible for coxib-associated CAD risk. The novel approach furthermore suggests that genetic studies may be useful to explore the clinical relevance of off-target drug effects.
Expression pattern of bcar3, a downstream target of Gata2, and its binding partner, bcar1, during Xenopus development
GENE EXPRESSION PATTERNS
Authors: Green, Yangsook Song; Kwon, Sunjong; Christian, Jan L.
Abstract
Primitive hematopoiesis generates red blood cells that deliver oxygen to the developing embryo. Mesodermal cells commit to a primitive blood cell fate during gastrulation and, in order to do so the mesoderm must receive non-cell autonomous signals transmitted from other germ layers. In Xenopus, the transcription factor Gata2 functions in ectodermal cells to generate or transmit the non-cell autonomous signals. Here we have identified Breast Cancer Antiestrogen Resistance 3 (bcar3) as a gene that is induced in ectodermal cells downstream of Gata2. Bcar3 and its binding partner Bcar1 function to transduce integrin signaling, leading to changes in cellular morphology, motility and adhesion. We show that gata2, bcar3 and bcar1 are co-expressed in ventral ectoderm from early gastrula to early tailbud stages. At later stages of development, bcar3 and bcar1 are co-expressed in the spinal cord, notochord, fin mesenchyme and pronephros but each shows additional unique sites of expression. These co-expression and unique expression patterns suggest that Bcar3 and Bcar1 may function together but also independently during Xenopus development. (C) 2015 Elsevier B.V. All rights reserved.